Nancy Kavanaugh, PhD

Nancy Kavanaugh is currently a senior director in global regulatory affairs CMC at MedImmune, a member of the AstraZeneca Group. She has been with MedImmune for more than 13 years in various positions in regulatory affairs including the vaccine and infectious disease therapy area and in regulatory CMC. Prior to joining MedImmune, Nancy spent 10 years at the Food and Drug Administration, Center for Biologics Evaluation and Research followed by 8 years as a quality and regulatory consulting position with Don Hill and Associates, Inc. with a focus in biologics and biotechnology products.